Osiris Announces Enrollment of Patients in a Clinical Trial Evaluating GrafixPL PRIME™ in the Treatment of Chronic Venous Leg Ulcers

World News: . []

COLUMBIA Md July 11 2018 GLOBE NEWSWIRE -- OTC Pink:OSIR), a regenerative medicine company focused on developing and marketing products for wound care orthopedics and sports medicine announced the initiation of its Multicenter Prosp ective,...

More news and information about Osiris Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Wednesday 11th July 2018

Published: .

Search for other references to "osiris" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us